ArticleOncotarget2016

Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis.

Julia Miriam Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.